As of 2025-07-15, the Relative Valuation of TherapeuticsMD Inc (TXMD) is (1.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.17 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -261.3%.
The range of the Relative Valuation is (1.69) - (1.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 10.1x | 8.3x |
| Forward P/E multiples | 9.3x - 15.7x | 12.5x |
| Fair Price | (1.69) - (1.83) | (1.89) |
| Upside | -244.3% - -256.7% | -261.3% |
| Date | P/E |
| 2025-07-14 | -6.45 |
| 2025-07-11 | -6.50 |
| 2025-07-10 | -6.61 |
| 2025-07-09 | -6.72 |
| 2025-07-08 | -6.50 |
| 2025-07-07 | -6.45 |
| 2025-07-03 | -6.50 |
| 2025-07-02 | -6.28 |
| 2025-07-01 | -6.23 |
| 2025-06-30 | -6.39 |
| 2025-06-27 | -6.17 |
| 2025-06-26 | -6.45 |
| 2025-06-25 | -6.56 |
| 2025-06-24 | -6.50 |
| 2025-06-23 | -6.12 |
| 2025-06-20 | -6.01 |
| 2025-06-18 | -5.95 |
| 2025-06-17 | -6.17 |
| 2025-06-16 | -5.95 |
| 2025-06-13 | -6.45 |
| 2025-06-12 | -6.61 |
| 2025-06-11 | -6.61 |
| 2025-06-10 | -6.67 |
| 2025-06-09 | -6.89 |
| 2025-06-06 | -6.89 |
| 2025-06-05 | -6.12 |
| 2025-06-04 | -6.23 |
| 2025-06-03 | -5.95 |
| 2025-06-02 | -6.06 |
| 2025-05-30 | -8.04 |
| 2025-05-29 | -8.15 |
| 2025-05-28 | -7.99 |
| 2025-05-27 | -8.21 |
| 2025-05-23 | -7.99 |
| 2025-05-22 | -7.99 |
| 2025-05-21 | -8.04 |
| 2025-05-20 | -8.21 |
| 2025-05-19 | -8.15 |
| 2025-05-16 | -8.26 |
| 2025-05-15 | -8.04 |
| 2025-05-14 | -8.04 |
| 2025-05-13 | -8.37 |
| 2025-05-12 | -8.15 |
| 2025-05-09 | -8.04 |
| 2025-05-08 | -7.71 |
| 2025-05-07 | -7.62 |
| 2025-05-06 | -7.77 |
| 2025-05-05 | -7.85 |
| 2025-05-02 | -7.82 |
| 2025-05-01 | -7.66 |